Protecting Ovary Function During Stem Cell Transplant for Aplastic Anemia
Part of Blood & lymphatic clinical trials.
This study tests whether a medication called goserelin can help protect a woman's fertility and menstrual cycles during a stem cell transplant treatment for aplastic anemia (a blood disorder). The goal is to see if the medication prevents permanent damage to the ovaries from the transplant procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aplastic anemia (SAA) and are scheduled to receive a stem cell transplant
- You are female, between 14 and 50 years old, and have regular periods before transplant
- Your heart, liver, and kidneys are functioning well enough to safely participate
- You have not gone through menopause and do not have ovary or gynecological conditions like PCOS or endometriosis
- You are willing to take goserelin medication during the study and follow all study visits
- Your doctors expect you to survive at least one year after transplant so your recovery can be monitored
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a hormone injection called goserelin can help preserve fertility and menstrual function in young women receiving a stem cell transplant for blood cancer. The transplant itself can damage ovaries, so researchers want to see if this medication protects them.
This study tests whether a medication called goserelin can help preserve fertility and menstrual cycles in women undergoing stem cell transplantation for blood cancers. The goal is to see if this drug can prevent or reduce damage to the ovaries from the transplant procedure.
This early-phase study tests whether mobilized stem cells from bone marrow can help women with certain abnormal uterine lining problems become healthier and possibly improve fertility. It’s aimed at people who are not pregnant and meet specific diagnoses and test results.
This study looks at how a treatment called StemCell Regenera, which uses a growth factor medicine (Filgrastim), affects the blood of women with poor ovarian response or low egg reserve. The goal is to understand how the treatment might help reactivate the ovaries.
This study looks at how aplastic anemia affects reproductive and mental health in adults. By understanding these connections, doctors can provide better support for your overall well-being.
This trial tests two different sources of donor cells for a transplant in patients with severe aplastic anemia (a condition where the bone marrow stops making enough blood cells). The study compares using cells from blood alone versus cells from both bone marrow and blood, to see which approach works better.
Hear when a new Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.